Article

Generic Drug Growth Highlights AJPB Week in Review

Author(s):

Lauren Santye, Assistant Editor

Most read articles of the week on The American Journal of Pharmacy Benefits.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Related Content
OPC 2025: Advancing Precision Oncology Through Pharmacy-Led Innovation
June 19th 2025

OPC 2025: Advancing Precision Oncology Through Pharmacy-Led Innovation

Alana Hippensteele, Lead Editor
Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care
June 17th 2025

Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Nonpharmacist Membership on Boards of Pharmacy Continues to Expand
June 19th 2025

Nonpharmacist Membership on Boards of Pharmacy Continues to Expand

Marilyn N. Bulloch, PharmD, BCPS, FCCM, SPP
S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk
June 3rd 2025

S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk

Alexandra Gerlach, Associate Editor
ASCO 2025: Real-World Outcomes of Frontline ICI Therapy in BRAF-Mutated Melanoma in the Community Setting
June 19th 2025

ASCO 2025: Real-World Outcomes of Frontline ICI Therapy in BRAF-Mutated Melanoma in the Community Setting

Janet Espirito, PharmD Alana Hippensteele, Lead Editor
Kidney tissue with calcified and sclerotic changes, interstitial fibrosis, kidney damage, renal dysfunction
June 19th 2025

Remnant Cholesterol Directly Associated With Higher Risk of Chronic Kidney Disease Development

Luke Halpern, Assistant Editor